Caresite®
Choose a category or subcategory
Luer-activated valve developed as needle-free injection port in IV applications
Caresite® is a needleless connector that can be used for infusion and transfusion therapy. It is designed for aspiration, injection, or intravenous infusion of fluids upon insertion of a male luer fitting.
Caresite® allows multiple usage through activation of the needle-free connector by attaching a luer slip / luer lock connector such as a syringe or IV tubing.
Advantages
Luer-Slip and Luer-Lock compatible
- Easy access for Luer-Slip and Luer-Lock connections. Suitable for several IV procedures (e.g. Luer Lock connections, etc.).1 Do not leave connected luer slip syringes unattended.
Easy disinfection
- Smooth surfaces designed for easy cleaning.5
- Caresite is alcohol resistant.1
Easy to inspect and to flush
- Open fluid path designed to minimize areas where bacteria can collect.
- Clear design helps verify proper flush.
- Can be effectively flushed of blood or fluids.7
Blood and lipid compatible
- Caresite® is compatible with lipids and blood.1,8
Average fluid displacement 0.029 ml (positive)
- Designed to reduce the risk of catheter occlusion.1,9,10,11,12
Designed to minimize slips and touch contamination
- Ergonomic design provides easy access by allowing a good grip and easy connection.1
Highly pressure resistant
- The standalone Caresite® LAD is suitable for use with power injectors which allows more flexibility. Pressure resistance up to 400 psi @ 15 mL / sec.1
Technical data
- Flow rate 208 mL / min1
- Priming volume 0.22 mL1
- Not made with PVC1
- Not made with DEHP1
- Not made with Latex / Natural rubber1
Tested for 1,000 activations
- Allows multiple access for direct aspiration or fluid injection.13
MRI compatible or conditional
- No metal parts contained.1
Compatibility
- Compatible with SwabCap – disinfection cap.1
Patient population
- The device can be used for all patients for which infusion therapy is prescribed. No gender or age-related limitations. There are no patient population restrictions.1
Risk prevention:
Sharps Injury
- Needle-free systems are designed to provide convenient and safe needle-free IV access for injection, aspiration or parallel infusion.4,6
Air Embolism
- A closed system helps to reduce the risk of air embolism due to the self-sealing valve which avoids intake of air. 2,3,5,14
Chemical contamination
- A closed system reduces the risk of chemical contamination as the valve prevents spillage / drug exposure. 2,3,5,14
Microbial contamination / Airborne contamination / Touch contamination
- Product does not allow the entry of external contaminants in the system, forming an effective microbial barrier when exposed to a microbial burden. Effective barrier to microbial contamination when swabbed with alcohol pad per the instruction for use. Helps to prevent bloodstream infections. Swabbable valve forms a closed system as it is designed to prevent microbial ingress and the escape of contaminants.2,5
- Internal data
- Test report - Evaluation of the microbial barrier performance of Caresite® valve against sporesog Bacillussubtilis signed by Prof. Dr. med. M.Exner and Dr. rer. nat. J. Gebel, Report DMT 2013-412, 11.12.2013
- Test Report - Closed system test by means of Sodium Fluorescein signed by Dr. rer. nat. J. Brünke Quality Labs BT GmbH Nuremberg, Report 1678.2-1, 28.05.2013
- American Nurses Association – Independent Study Module: Needlestick Safety and Prevention written by Mary Foley, MS, RN and Annemarie T. Leyden, EdD, RN
- White Paper: CARESITE® Luer Access Device (LAD): 7- Day Microbial Barrier Performance, B. Braun Medical Inc., Bethlehem, PA., 15-5669 SW, 2017
- Review Article - Review on Needle Free Drug Delivery Systems, International Journal of Pharma Research & Review, written by Bhagyashri Chavan, Abha Doshi, Yashwant Malode, Balu Misal, Sept 2013; 2(9):30-36
- White Paper: CARESITE Luer Access Device: Blood Clearance Test of the Needleless Connector, B. Braun Medical Inc., Bethlehem, PA., CS05_ 07/10_EB, 2010
- White Paper: CARESITE Luer Access Device: Mechanical Hemolysis Test of the Needleless Connector, B. Braun Medical Inc., Bethlehem, PA., CS06_ 07/10_EB, 2010
- Guidelines: Infusion Therapy Standards of Practice, page 152 published in Journal of Infusion Nursing (January/February 2016, Volume 39, Number 1S)
- Study: Efficacy of a “saline only” flush protocol utilizing the Ultrasite® positive displacement device. Susan Silverstein, RN, CRNI, Nurse Consultant, Omnicare Infusion Services of Northern Illinois, January 2003
- Study: Journal of Vascular Access Devices, Volume 5, Issue 4, 2000, Page 31-33, The effects of positive pressure devices on catheter occlusions, Loretta Berger RN, CRNI
- Study: Leone M, Dillon R. Catheter outcomes in home infusion. JIN March/April 2008 Vol 31, No2.
- Whitepaper: Caresite Confirmation 1,000 activations (2019)
- Test report - Evaluation of the microbial barrier performance of the female valve Caresite® by touch contamination with Staphylococcus aureus signed by Prof. Dr. med. M.Exner and Dr. rer. nat. J. Gebel, Report DMT 2014-194, 09.12.2014
- Nygren O. Olofsson E. Johannson L. NIOSH Definition of Closed-System Drug-Transfer Devices. Oxford Journals. Annals of Occupational Hygiene. 2009: 53(5): 549. doi: 10.1093/annhyg/mep030
Caresite® – in short words
Videos
-
Caresite®- in short words
-
Caresite
Veterinary